Profile data is unavailable for this security.
About the company
Venture Life Group PLC is a United Kingdom-based consumer self-care company. The Company is focused on product development and commercialization within the global consumer healthcare sector. Its product portfolio includes Balance Activ in the area of women's intimate healthcare, Earol supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, and Gelclair and Pomi-T for oncology support products that provide symptomatic relief for some of the side effects associated with cancer and its treatment. Its products include Baby Earol, EarolSwim, Earol, Glucogel, and Lift Glucose. The products, which are recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples and are sold in over 90 countries worldwide. In the United Kingdom and The Netherlands, products are supplied direct by the Company to retailers, elsewhere they are supplied by its international distribution partners.
- Revenue in GBP (TTM)18.53m
- Net income in GBP-295.00k
- Incorporated2005
- Employees58.00
- LocationVenture Life Group PLCUnit 12, The Courtyard, Eastern RoadBRACKNELL RG12 2XBUnited KingdomGBR
- Phone+44 134 457 8004
- Fax+44 134 474 2970
- Websitehttps://www.venture-life.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ohki Healthcare Holdings Co Ltd | 1.68bn | 11.40m | 86.43m | 648.00 | 7.35 | 0.5382 | 6.52 | 0.0513 | 178.43 | 178.43 | 26,346.69 | 2,435.83 | 2.26 | 9.83 | 4.34 | 554,637,400.00 | 1.53 | 1.77 | 6.23 | 7.74 | 5.31 | 5.26 | 0.677 | 0.6977 | 0.8306 | -- | 0.2686 | 14.17 | 4.42 | 4.74 | 19.41 | 2.21 | 45.68 | 6.47 |
| Recce Pharmaceuticals Ltd | 3.99m | -11.10m | 86.87m | -- | -- | -- | -- | 21.77 | -0.0899 | -0.0899 | 0.0325 | -0.0106 | 0.8203 | -- | 25.91 | -- | -228.15 | -150.15 | -- | -318.01 | -- | -- | -278.12 | -340.57 | -- | -17.98 | 1.49 | -- | 47.14 | 46.35 | -21.33 | -- | 34.71 | -- |
| Starpharma Holdings Ltd | 3.03m | -5.17m | 86.99m | 50.00 | -- | 8.81 | -- | 28.71 | -0.024 | -0.024 | 0.014 | 0.0454 | 0.188 | 0.5663 | 0.9444 | -- | -32.10 | -26.74 | -39.68 | -32.74 | 79.08 | 75.64 | -170.77 | -259.38 | 3.95 | -- | 0.1122 | -- | -40.04 | -2.25 | -22.35 | -- | -19.60 | -- |
| Venture Life Group PLC | 18.53m | -295.00k | 87.42m | 58.00 | -- | 1.20 | 75.29 | 4.72 | -0.0022 | -0.0006 | 0.1454 | 0.5875 | 0.1549 | 1.03 | 1.63 | 319,431.00 | -0.2467 | 0.9986 | -0.271 | 1.16 | 53.34 | 41.69 | -1.59 | 3.38 | 1.41 | 2.01 | 0.2363 | 0.00 | 18.90 | 5.65 | -1,250.00 | -- | -61.25 | -- |
| Sakar Healthcare Ltd | 18.58m | 2.03m | 88.90m | 342.00 | 43.36 | -- | 22.86 | 4.79 | 11.45 | 11.45 | 104.95 | -- | -- | -- | -- | 6,750,901.00 | -- | 4.73 | -- | 5.64 | 52.54 | 45.55 | 10.92 | 9.87 | -- | 3.66 | -- | -- | 15.80 | 16.44 | 49.96 | 12.71 | 19.34 | -- |
| BRIM Biotechnology Inc | 67.59k | -8.97m | 88.93m | -- | -- | 2.13 | -- | 1,315.72 | -3.03 | -3.03 | 0.0227 | 13.54 | 0.0017 | -- | 0.2562 | -- | -22.31 | -30.03 | -23.29 | -32.36 | 45.70 | -- | -13,405.20 | -1,623.06 | 27.36 | -1,899.89 | 0.0111 | -- | -75.56 | -- | 54.15 | -- | 310.04 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Slater Investments Ltd.as of 18 Aug 2025 | 35.85m | 28.30% |
| BGF Investment Management Ltd.as of 27 Jun 2025 | 11.59m | 9.15% |
| River Global Investors LLPas of 30 Jun 2025 | 10.33m | 8.15% |
| Hargreaves Lansdown Asset Management Ltd.as of 31 Dec 2024 | 9.15m | 7.22% |
| TrinityBridge Ltd.as of 03 Nov 2025 | 8.85m | 6.99% |
| Stonehage Fleming Investment Management Ltd.as of 30 Jun 2025 | 8.42m | 6.65% |
| Chelverton Asset Management Ltd.as of 31 Dec 2024 | 4.36m | 3.45% |
| Harwood Capital LLPas of 15 Dec 2025 | 3.75m | 2.96% |
| Hargreaves Lansdown Fund Managers Ltd.as of 03 Nov 2025 | 2.17m | 1.71% |
| Quilter Cheviot Ltd.as of 03 Nov 2025 | 1.31m | 1.04% |
